NA Genetic Testing Market- Industry Trends and Forecast to 2035

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	249 Pages	Data Bridge Market Research	December, 2023	DAABD18458935

Best Price Guarantee
Price	from $3,500
Length	249 Pages
Publisher	Data Bridge Market Research
Published Date	December, 2023
SKU	DAABD18458935

NA Genetic Testing Market- Industry Trends and Forecast to 2035

North America genetic testing market is expected to reach USD 25,045,918.59 thousand by 2031 from USD 7,381,854.06 thousand in 2023 with growing at a CAGR of 16.8% during the forecast period of 2024 to 2031.
Market Segmentation
North America Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, New Born Screening, Predictive and Presymptomatic Testing, and Other Types), Technology (DNA sequencing, Polymerase Chain Reaction, Microarrays, Whole Genome Sequencing, Fluorescence In Situ Hybridization (FISH), and Others), Diseases (Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Fragile X Syndrome, and Other Diseases), End User (Hospitals, Clinics, Diagnostic Centers, Private Clinics, Laboratory Service Providers, and Private Laboratories), By Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031

Overview of Global Genetic Testing Market Dynamics

Driver
• Growing prevalence of genetic disorders

Restrain

• High cost of genetic testing

Opportunity

• Strategic initiatives by the key market player

Market Players

Some of the key market players for North America genetic testing market are:

• Thermo Fisher Scientific Inc.
• Invitae Corporation
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• Illumina, Inc.
• QIAGEN
• F. Hoffmann-La Roche Ltd.
• Fulgent Genetics
• Myriad Genetics, Inc.
• Abbott
• Eurofins Scientific
• Sorenson Genomics
• BIO-HELIX
• Biocartis
• Cepheid (A subsidiary of Danaher)
• PacBio
• ELITechGroup
• Genes2Me
• Eugene Labs
• Otogenetics
• Mapmygenome
• MedGenome
• BioReference
• Natera, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Genetic Testing Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Type Lifeline Curve; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market Application Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestal Analysis; 4.2 Porters 5 Forces; 4.3 Epidemiology
5 North America Genetic Testing Market: Regulations
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Prevalence Of Genetic Disorders; 6.1.2 Increase In The Adoption Of Next Generation Sequencing; 6.1.3 Wide Product Portfolio Offered By A Major Player; 6.1.4 Increase The Trend Toward Personalized Medication; 6.2 Restraints; 6.2.1 High Cost Of Genetic Testing; 6.2.2 Cyber Security Concerns In Genomics; 6.3 Opportunities; 6.3.1 Strategic Initiatives By The Key Market Player; 6.3.2 Technological Advancement In The Field Of Genetic Testing; 6.3.3 Increasing Research And Development For Genetic Testing; 6.4 Challenges; 6.4.1 Lack Of Skilled Professionals To Perform Genetic Testing; 6.4.2 Stringent Regulation Policy For Genetic Testing
7 North America Genetic Testing Market, By Type: 7.1 Overview; 7.2 Diagnostic Testing; 7.3 Prenatal Testing; 7.3.1 Non-invasive Screening; 7.3.1.1 Whole Genome Sequencing; 7.3.1.2 Counting Of Cfdna Fragments; 7.3.1.3 Others; 7.3.2 By Condition; 7.3.2.1 Trisomy 21; 7.3.2.2 Klinefelter Syndrome; 7.3.2.3 Jacobs Syndrome; 7.3.2.4 Cystic Fibrosis; 7.3.2.5 Turner Syndrome; 7.3.2.6 Trisomy 18; 7.3.2.7 Hemophilia; 7.3.2.8 Trisomy 13; 7.3.2.9 Microdeletion Syndrome; 7.3.2.10 Fetal Gender; 7.3.2.11 Others; 7.3.3 By Screening Type; 7.3.3.1 Carrier Sequencing; 7.3.3.2 Sequential Sequencing; 7.3.4 Maternal Serum Quad Screening; 7.4 New-born Screening; 7.4.1 Sickle Cell Disease; 7.4.2 Congenital Hypothyroidism; 7.4.3 Phenylketonurina (Pku); 7.4.4 Galactosemia; 7.4.5 Maple Syrup Urine Disease; 7.4.6 Others; 7.5 Predictive And Presymptomatic Testing; 7.6 Carrier Testing; 7.6.1 Molecular Screening Test; 7.6.2 Biochemical Screening Test; 7.6.2.1 Expanded Carrier Screening; 7.6.2.2 Predesigned Panel Testing; 7.6.2.3 Custom-made Panel Testing; 7.6.2.4 Targeted Disease Carrier Screening; 7.6.2.4.1 Hematological Conditions; 7.6.2.4.2 Pulmonary Conditions; 7.6.2.4.3 Neurological Conditions; 7.6.2.4.4 Other Conditions; 7.7 Other Types
8 North America Genetic Testing Market, By Technology: 8.1 Overview; 8.2 Polymerase Chain Reaction; 8.2.1 Real-time Pcr (Qpcr); 8.2.2 Digital Pcr (Dpcr); 8.2.3 Reverse Transcription Pcr (Rt-pcr); 8.2.4 Hot-start Pcr; 8.2.5 Multiplex Pcr; 8.2.6 Other Pcr; 8.3 Dna Sequencing (Ngs-based Testing); 8.3.1 Next Generation Sequencing (Ngs); 8.3.2 Sanger Sequencing (Single Gene); 8.3.3 Other; 8.4 Whole Genome Sequencing; 8.5 Microarrays; 8.5.1 Dna Microarrays; 8.5.2 Protein Microarrays; 8.5.3 Other Microarrays; 8.6 Fluorescence In Situ Hybridization (Fish); 8.7 Others
9 North America Genetic Testing Market, By Diseases: 9.1 Overview; 9.2 Cancer; 9.2.1 Breast; 9.2.2 Colon; 9.2.3 Lung; 9.2.4 Prostate; 9.2.5 Others; 9.3 Sickle Cell Anemia; 9.4 Thalassemia; 9.5 Rare Genetic Disorder; 9.5.1 Trisomy 21; 9.5.2 Monosomy X; 9.5.3 Trisomy 13; 9.5.4 Microdeletion Syndrome; 9.5.5 Trisomy 18; 9.5.6 Others; 9.6 Fragile X Syndrome; 9.7 Duchenne Muscular Dystrophy; 9.8 Huntington's Disease; 9.9 Cystic Fibrosis; 9.10 Others
10 North America Genetic Testing Market, By End User: 10.1 Overview; 10.2 Hospitals; 10.3 Clinics; 10.4 Diagnostic Centers; 10.5 Private Clinics; 10.6 Laboratory Service Providers; 10.7 Private Laboratories
11 North America Genetic Testing Market, By Region: 11.1 Overview; 11.2 North America; 11.2.1 U.S.; 11.2.2 Canada; 11.2.3 Mexico
12 North America Genetic Testing Market, Company Landscape: 12.1 Company Share Analysis: North America
13 Swot Analysis
14 Company Profiles: 14.1 Illumina, Inc.; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Cepheid; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development; 14.3 Fulgent Genetics; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Perkinelmer Inc.; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Thermo Fisher Scientific Inc.; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development; 14.5.5.1 Collaboration; 14.6 Bioreference; 14.6.1 Company Snapshot; 14.6.2 Revenue Analysis; 14.6.3 Product Portfolio; 14.6.4 Recent Development; 14.7 Elitechgroup; 14.7.1 Company Snapshot; 14.7.2 Product Portfolio; 14.7.3 Recent Developments; 14.8 Eurofins Scientific; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Development; 14.9 Invitae Corporation; 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 14.9.4 Recent Developments; 14.10 Myriad Genetics; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Development; 14.11 Abbott; 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development; 14.12 Biocartis; 14.12.1 Company Snapshot; 14.12.2 Revenue Analysis; 14.12.3 Product Portfolio; 14.12.4 Recent Developments; 14.12.4.1 Partnership; 14.13 Bio-helix; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Development; 14.14 Bio-rad Laboratories, Inc.; 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Developments; 14.15 Eugene Labs; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 F. Hoffmann-la Roche Ltd; 14.16.1 Company Snapshot; 14.16.2 Revenue Analysis (Parent Company); 14.16.3 Product Portfolio; 14.16.4 Recent Development; 14.17 Genes2me; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development; 14.18 Mapmygenome; 14.18.1 Company Snapshot; 14.18.2 Product Portfolio; 14.18.3 Recent Development; 14.19 Medgenome; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Natera, Inc.; 14.20.1 Company Snapshot; 14.20.2 Revenue Analysis; 14.20.3 Product Portfolio; 14.20.4 Recent Development; 14.21 Otogenetics; 14.21.1 Company Snapshot; 14.21.2 Product Portfolio; 14.21.3 Recent Development; 14.22 Pacbio; 14.22.1 Company Snapshot; 14.22.2 Revenue Analysis; 14.22.3 Product Portfolio; 14.22.4 Recent Development; 14.23 Qiagen; 14.23.1 Company Snapshot; 14.23.2 Revenue Analysis; 14.23.3 Product Portfolio; 14.23.4 Recent Development; 14.24 Sorenson Genomics; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 North America Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 2 North America Genetic Testing Market, By Type, 2022-2031 (Units); Table 3 North America Diagnostic Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 4 North America Prenatal Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 5 North America Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 6 North America Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Uunits); Table 7 North America Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 8 North America Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 9 North America Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 10 North America Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 11 North America Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 12 North America New Born Screening In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 13 North America New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 14 North America Predictive And Presymptomatic Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 15 North America Carrier Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 16 North America Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 17 North America Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 18 North America Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 19 North America Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 20 North America Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 21 North America Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 22 North America Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 23 North America Other Types In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 24 North America Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 25 North America Polymerase Chain Reaction In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 26 North America Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 27 North America Dna Sequencing (Ngs-based Testing) In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 28 North America Dna Sequencing (Ngs-based Testing) In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 29 North America Whole Genome Sequencing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 30 North America Microarrays In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 31 North America Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 32 North America Fluorescence In Situ Hybridization (Fish) In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 33 North America Others In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 34 North America Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 1 North America Cancer In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 2 North America Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 3 North America Sickle Cell Anemia In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 4 North America Thalassemia In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 5 North America Rare Genetic Disorder In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 6 North America Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 7 North America Fragile X Syndrome In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 8 North America Duchenne Muscular Dystrophy In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 9 North America Huntington's Disease In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 10 North America Cystic Fibrosis In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 11 North America Others In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 12 North America Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 13 North America Hospitals In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 14 North America Clinics In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 15 North America Diagnostic Centers In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 16 North America Private Clinics In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 17 North America Laboratory Service Providers In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 18 North America Private Laboratories In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 19 North America Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 20 North America Genetic Testing Market, By Country, 2022-2031 (Usd Thousand); Table 21 North America Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 22 North America Genetic Testing Market, By Type, 2022-2031 (Units); Table 23 North America Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 24 North America Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 25 North America Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 26 North America Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 27 North America Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 28 North America Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 29 North America Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 30 North America New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 31 North America Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 32 North America Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 33 North America Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 34 North America Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 35 North America Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 36 North America Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 37 North America Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 38 North America Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 39 North America Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 40 North America Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 41 North America Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 42 North America Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 43 North America Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 44 North America Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 45 North America Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 46 U.S. Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 47 U.S. Genetic Testing Market, By Type, 2022-2031 (Units); Table 48 U.S. Genetic Testing Market, By Type, 2022-2031 (Asp); Table 49 U.S. Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 50 U.S. Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 51 U.S. Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 52 U.S. Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 53 U.S. Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 54 U.S. Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Asp); Table 55 U.S. Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 56 U.S. Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 57 U.S. Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 58 U.S. Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Asp); Table 59 U.S. New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 60 U.S. Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 61 U.S. Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 62 U.S. Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Asp); Table 63 U.S. Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 64 U.S. Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 65 U.S. Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 66 U.S. Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 67 U.S. Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 68 U.S. Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 69 U.S. Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 70 U.S. Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 71 U.S. Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 72 U.S. Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 73 U.S. Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 74 U.S. Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 75 U.S. Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 76 U.S. Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 77 U.S. Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 78 Canada Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 79 Canada Genetic Testing Market, By Type, 2022-2031 (Units); Table 80 Canada Genetic Testing Market, By Type, 2022-2031 (Asp); Table 81 Canada Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 82 Canada Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 83 Canada Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 84 Canada Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 85 Canada Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 86 Canada Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Asp); Table 87 Canada Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 88 Canada Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 89 Canada Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 90 Canada Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Asp); Table 91 Canada New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 92 Canada Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 93 Canada Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 94 Canada Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Asp); Table 95 Canada Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 96 Canada Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 97 Canada Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 98 Canada Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 99 Canada Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 100 Canada Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 101 Canada Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 102 Canada Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 103 Canada Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 104 Canada Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 105 Canada Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 106 Canada Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 107 Canada Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 108 Canada Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 109 Canada Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 110 Mexico Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 111 Mexico Genetic Testing Market, By Type, 2022-2031 (Units); Table 112 Mexico Genetic Testing Market, By Type, 2022-2031 (Asp); Table 113 Mexico Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 114 Mexico Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 115 Mexico Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 116 Mexico Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 117 Mexico Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 118 Mexico Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Asp); Table 119 Mexico Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 120 Mexico Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 121 Mexico Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 122 Mexico Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Asp); Table 123 Mexico New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 124 Mexico Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 125 Mexico Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 126 Mexico Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Asp); Table 127 Mexico Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 128 Mexico Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 129 Mexico Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 130 Mexico Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 131 Mexico Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 132 Mexico Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 133 Mexico Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 134 Mexico Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 135 Mexico Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 136 Mexico Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 137 Mexico Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 138 Mexico Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 139 Mexico Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 140 Mexico Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 141 Mexico Genetic Testing Market, By End User, 2022-2031 (Usd Thousand)
List Of Figures: Figure 1 North America Genetic Testing Market: Segmentation; Figure 2 North America Genetic Testing Market: Data Triangulation; Figure 3 North America Genetic Testing Market: Droc Analysis; Figure 4 North America Genetic Testing Market: North America Vs Regional Market Analysis; Figure 5 North America Genetic Testing Market: Company Research Analysis; Figure 6 Multivariate Modelling; Figure 7 North America Genetic Testing Market: Dbmr Market Position Grid; Figure 8 North America Genetic Testing Market: Application Coverage Grid; Figure 9 North America Genetic Testing Market: Vendor Share Analysis; Figure 10 North America Genetic Testing Market: Segmentation; Figure 11 Increasing Prevalence Of Genetic Disorders Are Expected To Drive The North America Genetic Testing Market In The Forecast Period Of 2024 To 2031; Figure 12 Diagnostic Testing Segment Is Expected To Account For The Largest Share Of The North America Genetic Testing Market In 2024 & 2031; Figure 13 North America Is Expected To Dominate The North America Genetic Testing Market And Asia-pacific Expected To Grow With The Highest Cagr In The Forecast Period Of 2024 To 2031; Figure 14 Asia-pacific Is The Fastest Growing Market For Genetic Testing Manufacturers In The Forecast Period Of 2024 To 2031; Figure 15 Drivers, Restraints, Opportunities, And Challenges Of North America Genetic Testing Market; Figure 16 North America Genetic Testing Market: By Type, 2023; Figure 17 North America Genetic Testing Market: By Type, 2024-2031 (Usd Thousand); Figure 18 North America Genetic Testing Market: By Type, Cagr (2024-2031); Figure 19 North America Genetic Testing Market: By Type, Lifeline Curve; Figure 20 North America Genetic Testing Market: By Technology, 2023; Figure 21 North America Genetic Testing Market: By Technology, 2024-2031 (Usd Thousand); Figure 22 North America Genetic Testing Market: By Technology, Cagr (2024-2031); Figure 23 North America Genetic Testing Market: By Technology, Lifeline Curve; Figure 24 North America Genetic Testing Market: By Diseases, 2023; Figure 25 North America Genetic Testing Market: By Diseases, 2023-2031 (Usd Thousand); Figure 26 North America Genetic Testing Market: By Diseases, Cagr (2023-2031); Figure 27 North America Genetic Testing Market: By Diseases, Lifeline Curve; Figure 28 North America Genetic Testing Market: By End User, 2023; Figure 29 North America Genetic Testing Market: By End User, 2024-2031 (Usd Thousand); Figure 30 North America Genetic Testing Market: By End User, Cagr (2024-2031); Figure 31 North America Genetic Testing Market: By End User, Lifeline Curve; Figure 32 North America Genetic Testing Market: Snapshot (2023); Figure 33 North America Genetic Testing Market: Company Share 2023 (%)